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3 Address: Department of Ophthalmology, Nizwa Hospital, PB-1222, Nizwa 611, Oman. Tel.: +968 99360568; fax: +968 25211908.Mary K. Jacob, DO, MRCOphth a,⇑; Cecil Pinheiro, MBBS, DO a,1; Prasad George, MD, FRCPEdin, FRCPI b,2; Zafar A. Zaidi, MD a,3AbstractSymptomatic choroidal metastasis (CM) is a rare presenting feature of disseminated lung malignancy. Detection of the primary
malignancy usually precedes ocular findings. We report a rare case of blurred vision secondary to bilateral CM as the sole initial
manifestation of disseminated lung malignancy in a female patient. Pulmonary symptoms appeared 2 months later. She received
radiotherapy and palliative chemotherapy and survived for 7 months after the initial presentation.
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Choroidal metastasis is rare in disseminated extraocular
malignancy whereas it is common with intraocular malignant
tumors. Leading cause of CM is reported to be carcinoma of
the lung in males and carcinoma of the breast in females.
However, clinical reports of female patients presenting with
ocular symptoms as the initial manifestation of lung carci-
noma are rare.
Case report
A 56 year old woman presented with blurred vision in the
Left eye for 3 weeks. There were no other systemic com-
plaints and there was no history of any associated systemic
diseases.Her best corrected snellens visual acuity was 6/36 in the
right eye and 2/60 in the left. Anterior segment examination
was within normal limits in both eyes. Fundoscopy in right eye
revealed a moderately elevated subretinal mass temporally in
the midperipheral retina. Left eye showed a moderately ele-
vated subretinal mass inferiorly associated with exudative ret-
inal detachment involving the macula. (Fig. 1A and B) Fundus
Fluorescein Angiography (Fig. 1C and D) and A-B Scan ultra-
sound (Fig. 2) supported a clinical suspicion of bilateral cho-
roidal metastasis. She was evaluated by physicians and an
oncology team to find out the site of primary malignancy.
CT of Chest showed a heterogeneous contrast enhancing
lesion with a hypodense area in the left lower lobe associated
with pleural effusion and multiple rounded pulmonary nod-
ules scattered in both lungs (Fig. 3E). CT of abdomen showed
renal and liver metastasis.e:
al.com
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Figure 2. A-B Scan Ultrasound showing a dome shaped mass with
variable reflectivity.
292 M.K. Jacob et al.CT Scan of head showed metastatic deposits in the right
frontal bone and meninges. Fine needle aspiration biopsy
from left lung showed atypical cells suspicious of malignancy,
which could not be characterized further. PET/CT Scan was
highly suggestive of disseminated malignancy involving the li-
ver (Fig. 3F), skull, meninges and bones (Fig. 4).
Two months after the initial presentation she developed
cough with hemoptysis and weight loss. She was commenced
on radiotherapy followed by chemotherapy for palliation. She
survived for 7 months after the initial presentation.
Discussion
Metastasis is the most common intraocular malignancy
with choroid being the most preferred site of interest owing
to its abundant vascular supply from the posterior ciliary
arteries.1–3 Perls reported the first case of choroid metastasis
in 1872.3
Incidence of CM from metastatic lung disease was re-
ported to be 2–6.7% in clinical trials.3 However clinical re-
ports of patients presenting with symptomatic CM as the
initial manifestation of lung malignancy are rare.2,4,6,7 Preva-
lence of symptomatic CM is reported to be 1–3%.7 Breast
and lungs are the frequent primary sites followed by GIT,
ovary and thyroid.3
Whole body 18-Fluoro 2-deoxyglucose PET/CT scan is
widely used now for screening, staging and management of
patients with cancer.2
CM can result in a marked decrease in vision usually
<6/60. It is very sensitive to radiotherapy and chemotherapy.Figure 1. Colour fundus photographs of the right (A) and left eye (B) showing
left eye. Fluoresceine angiography of right (C) and left (D) eyes showing diffus
the extent of retinal detachment.Aggressive treatment will decrease the metastasis size, but
most of the patients will not show much improvement in
vision.5,7 Treatment options for CM depend on both systemic
and ocular status.2 Life expectancy of patients with CM in
general is about 6–9 months.8 Palliative treatment should
be offered to avoid further deterioration of vision and to
maintain the quality of life during the remaining life span of
the patient.9
Though CM is described as a rare entity, with increase in
the cancer rates and cancer survival, it will become a major
cause of visual impairement.7,10 Acute visual loss in a healthy
patient as the first sign of an unknown primary tumor cansubretinal mass in both eyes with associated serous retinal detachment in
e hyperfluorescence of the tumor (blue arrow) and white arrows showing
Figure 3. CT-Scan of chest (E) showing mass lesion in the left lower lobe of lung (white arrow) and multiple pulmonary nodules. PET/CT scan of abdomen
(F) showing hepatic metastasis.
Figure 4. PET/CT Scan showing metastasis in the skull (G) and bones(H).
Choroidal metastasis as the first manifestation of carcinoma 293easily be overlooked by ophthalmologists as well as by the
patient. This report is a reminder that malignancy can present
atypically and could be of assistance to clinicians who
encounter a similar rare scenario.
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